JCO Precision OncologyJCO精准肿瘤学
JCO Precision Oncology(英文缩写 JCO PRECIS ONCOL),ISSN 2473-4284,eISSN 2473-4284,中文译名:JCO精准肿瘤学 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-25 至 2026-09-25，按本站收录文献的发表日期统计。
期刊介绍
JCO Precision Oncology 最新收录文献
-
1. Cross-Ancestry and Phenome-Wide Associations of Cancer-Specific Polygenic Risk Scores.
1. 癌症特异性多基因风险评分的跨 ancestry 与全表型组关联研究PMID:日期:2026-09-01Genome-wide association studies have identified many common variants associated at low effect sizes with various cancers. Summing the effects of these variants into polygenic risk scores (PRS) can imp…
-
2. Clinicopathologic Features, Treatment Patterns, and Outcomes of Microsatellite Instability-High Gastric and Gastroesophageal Junction Adenocarcinoma: A Single-Institution Retrospective Analysis.
2. 微卫星高度不稳定性胃癌及胃食管结合部腺癌的临床病理特征、治疗模式与结局：一项单中心回顾性分析PMID:日期:2026-09-01[中文摘要] 微卫星高度不稳定（MSI-H）和错配修复缺陷（dMMR）的胃或胃食管结合部（GEJ）腺癌是生物学上独特的肿瘤，已证实对免疫检查点抑制剂（ICIs）敏感。然而，真实世界治疗模式、疗效异质性及持久获益的预测因素仍定义不清。我们回顾性分析了在单中心接受治疗的活检确诊MSI-H/dMMR胃/GEJ腺癌患者。收集了临床病理、基因组、治疗及结局数据。分子谱分析包括ARID1A、RNF43、TP53、PIK3C…
-
3. Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.
3. 转移性癌症女性患者的纵向临床、生理学和分子学特征分析：一项多中心高精度肿瘤学研究的方案与可行性PMID:日期:2026-09-01A substantial proportion of patients receiving genomically matched therapies do not achieve clinical benefit, underscoring the influence of nongenetic factors on cancer outcomes. High-Definition Oncol…
-
6. {"_":"Exploring the Melanoma and Pancreatic Cancer Phenotype of a Potential Founder Variant, I49T (c.146T>C; p.Ile49Thr), in Individuals of Predominantly Mexican Ancestry.","i":["CDKN2A"]}
PMID:日期:2026-09-01Pathogenic/likely pathogenic variants (P/LPVs) in the gene cause an increased risk of melanoma (MEL) and pancreatic cancer (PANC). The variant I49T (c.146T>C), reported to be recurrent in Hispanics, h…
-
7. Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.
PMID:日期:2026-09-01Detection of molecular residual disease (MRD) using circulating tumor DNA (ctDNA) is strongly associated with recurrence risk in early triple-negative breast cancer (TNBC). Prior studies suggest that …
-
8. Anti-CD94 Monoclonal Antibody Dibotatug-Induced Response in a Refractory Primary CNS T-Cell Lymphoma.
8. 抗CD94单克隆抗体Dibotatug在难治性原发性中枢神经系统T细胞淋巴瘤中诱导的缓解PMID:日期:2026-09-01该文献暂无摘要。
-
9. Prospective Evaluation of Circulating Tumor DNA in Metastatic Hormone-Sensitive Prostate Cancer.
PMID:日期:2026-09-01There are few established prognostic biomarkers in metastatic hormone-sensitive prostate cancer (mHSPC). Disease volume and timing of metastases are prognostic and predictive factors but may be inadeq…
-
10. Predicting Targeted and Immunotherapeutic Response Outcomes in Melanoma With Single-Cell Raman Spectroscopy and Artificial Intelligence.
PMID:日期:2026-09-01Identifying reliable predictors of immunotherapeutic response in melanoma remains an outstanding challenge. Existing transcriptomic and proteomic profiling methods for the tumor-immune microenvironmen…